Skip to content

Screening for Neonatal Jaundice With a Mobile Health Device: a Validation Study in Oaxaca, Mexico.

Screening for Neonatal Jaundice With a Mobile Health Device: a Validation Study in Oaxaca, Mexico.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06276582
Enrollment
177
Registered
2024-02-26
Start date
2023-01-17
Completion date
2024-06-08
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice, Neonatal

Keywords

Neonatal jaundice, Screening, mobile health, low resource settings

Brief summary

The performance and accuracy of the smartphone application (app) Picterus Jaundice Pro (PicterusJP) will be validated by a cross-sectional study conducted in low resource settings in Mexico. Physics-based and machine learning-based models will be used to analyze the images obtained with the app and its performance will be compared.

Detailed description

A cross-sectional prospective study is taken place at Hospital General de Zona 1 in the city of Oaxaca, Mexico. Participants are recruited from the maternity ward and emergency room and data collection is conducted by one experienced pediatrician and one paediatrics' resident. After informed consent is obtained, background data including time and date or birth, birth weight, gestational age, parent's skin type according to Fitzpatrick scale and newborn's skin color according to Neomar's scale is being collected. Visual assessment is performed by the researchers using Kramer's scale. To obtain the bilirubin measurements with the smartphone app Picterus Jaundice Pro (Picterus JP), the calibration card is placed on the newborn's chest and a set of six images, 3 with and 3 without flash, are captured. The smartphones used to capture the images are Samsung A23, iPhone 11 and iPhone 15 Pro. Total serum bilirubin (TSB) levels are measured with a blood sample obtained within one hour of capturing the images and analyzed at the hospital laboratory facilities. Demographic and clinical characteristics will be analyzed by descriptive statistic. Bilirubin measurements correlation between Picterus JP using both models and TSB will be determined by Pearson's correlation coefficient. Systematic over or underestimation of bilirubin levels will be evaluated using Bland-Altman plots. Accuracy measurements will be determined using receiver operating characteristics (ROC) and area under the curve (AUC) analysis. To compare the correlations from both models, Fisher's r to z transformation approach will be applied

Interventions

DEVICEScreening for neonatal jaundice with a mobile health device

Picterus Jaundice Pro will be used to screen for neonatal jaundice by taking 6 photos of the newborns skin, where the Picterus calibration card is place.

Sponsors

Picterus AS
CollaboratorINDUSTRY
Instituto Mexicano del Seguro Social
CollaboratorOTHER_GOV
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 14 Days
Healthy volunteers
No

Inclusion criteria

* gestational age of 37 weeks or more * birth weight of 2500 g and above * newborns in whom a blood test had been ordered for any reason, irrespective of the study

Exclusion criteria

* newborns with congenital diseases * newborns transferred to pediatric wards for reasons unrelated to neonatal jaundice * newborns who had undergone phototherapy

Design outcomes

Primary

MeasureTime frameDescription
Enable high qualitative estimation of bilirubin levels in the blood of Mexican newborns using Picterus JP16 monthsEvaluate the smartphone-based screening tool Picterus for neonatal jaundice in Mexican newborns.

Secondary

MeasureTime frameDescription
Correlation between bilirubin measurements with Picterus JP and total serum bilirubin2 hoursPearson correlation coefficient

Other

MeasureTime frameDescription
Accuracy of Picterus JP to screen for neonatal jaundice16 monthsSensitivity, specificity, positive and negative predictive values

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026